Testing effectiveness (Phase 2)Study completedNCT04776629
What this trial is testing
A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors
Who this might be right for
PsoriasisInflammationCoronary Artery Disease+1 more
Abcentra 77